cas 2215028-64-9|| where to buy 6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

製品名:6-chloro-3-iodo-1-tetrahydropyran-2-yl-pyrazolo[3,4-b]pyrazine

IUPAC Name:6-chloro-3-iodo-1-(oxan-2-yl)-1H-pyrazolo[3,4-b]pyrazine

包装単位	有効在庫	価格（USD）
CM479274-1g	in stock	ſǕƙ
CM479274-5g	in stock	ƱȦɐƻ
CM479274-10g	in stock	ȦƻȷǕ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 2215028-64-9 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:2215028-64-9; 分子式:C10H10ClIN4O; 融点:-; SMILESコード:ClC1=CN=C2C(I)=NN(C3CCCCO3)C2=N1; 密度:

: カタログ番号:CM479274; 分子量:364.57; 沸点:; MDL番号:MFCD32220431; 保管方法:

: Pyrazolopyrazines; The pyrazolopyrazine ring system is a very interesting class of heterocyclic compounds considered as important scaffolds for many effective bioactive agents with low toxicity, antioxidant, anticonvulsant, antiparasitic, anti-inflammatory, antiviral, antibacterial, anti- Fungal and analgesic activity.

: GDC-1971; Protein tyrosine phosphatase SHP2 mediates RAS-driven MAPK signaling and has emerged in recent years as a target of interest in oncology, both for treating with a single agent and in combination with a KRAS inhibitor. GDC-1971 (formerly RLY-1971) is a SHP2 inhibitor currently in clinical trials in combination with KRAS G12C inhibitor divarasib (GDC-6036) for the treatment of solid tumors driven by a KRAS G12C mutation.